Balakrishna Kolli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Balakrishna Kolli has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Sarada P. Mishra
Polymer Science and Technology Centre, Naval Materials Research Laboratory, Shil-Badlapur Road; Ambernath 421506 India
6 shared publications- Asit Baran Samui
Institute of Chemical Technology
5 shared publications - Rambabu Gundla
Department of Chemistry, School of Science, GITAM University, Hyderabad 502102, Telangana, India
4 shared publications Tapan Kanai
Naval Materials Research Laboratory
4 shared publications- Naresh Kumar Katari
School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus University of KwaZulu‐Natal Durban South Africa
3 shared publications Someshwarnath Pandey
Laser Materials Processing Division, Raja Ramanna Centre for Advanced Technology; Indore 452013 India
3 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (29) , 26273-26291
New phenylcyclopropane-carbohydrazide furan derivatives with potent anticancer activity and EGFR inhibitory potential
Fifteen new phenylcyclopropane-carbohydrazide-containing furan derivatives are synthesised and thoroughly characterized using FT-IR, 1 H-NMR, 13 C-NMR, and HRMS spectroscopy techniques in the search for new anticancer drugs.
- 18 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (29) , 26273-26291
Open AccessNew phenylcyclopropane-carbohydrazide furan derivatives with potent anticancer activity and EGFR inhibitory potential
Fifteen new phenylcyclopropane-carbohydrazide-containing furan derivatives are synthesised and thoroughly characterized using FT-IR, 1 H-NMR, 13 C-NMR, and HRMS spectroscopy techniques in the search for new anticancer drugs.
- 1 October 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 61 (10) , 1903-1914
Synthesis and Molecular Docking Study of 2-Aroyl-3-phosphonylbenzofurans as Bacterial DNA Gyrase Inhibitors
A manganese(III)-catalyzed cross-dehydrogenative coupling of 2-aroylbenzofurans with phosphites to afford 2-aroyl-3-phosphonylbenzofurans is reported. The reaction proceeds via oxidation of dialkyl phosphonates to phosphoryl radicals by manganese(III) cations, which are subsequently reduced to manganese(II). This is followed by electron transfer, electrophilic addition, and sequential intermediate transformations that lead to the formation of the desired 2-aroyl-3-phosphonylbenzofurans. A series of 2-aroyl-3-phosphonylbenzofurans bearing various functional groups were synthesized in moderate to good yields. Molecular docking studies were performed to evaluate their inhibitory potential against the DNA gyrase enzyme. In addition, pharmacokinetic properties were assessed. Among the compounds tested, ligand 3c exhibited strong binding affinity (–7.8 kcal/mol) via hydrogen bonding, π–π stacking, and hydrophobic interactions.
- 1 October 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 61 (10) , 1903-1914
Synthesis and Molecular Docking Study of 2-Aroyl-3-phosphonylbenzofurans as Bacterial DNA Gyrase Inhibitors
A manganese(III)-catalyzed cross-dehydrogenative coupling of 2-aroylbenzofurans with phosphites to afford 2-aroyl-3-phosphonylbenzofurans is reported. The reaction proceeds via oxidation of dialkyl phosphonates to phosphoryl radicals by manganese(III) cations, which are subsequently reduced to manganese(II). This is followed by electron transfer, electrophilic addition, and sequential intermediate transformations that lead to the formation of the desired 2-aroyl-3-phosphonylbenzofurans. A series of 2-aroyl-3-phosphonylbenzofurans bearing various functional groups were synthesized in moderate to good yields. Molecular docking studies were performed to evaluate their inhibitory potential against the DNA gyrase enzyme. In addition, pharmacokinetic properties were assessed. Among the compounds tested, ligand 3c exhibited strong binding affinity (–7.8 kcal/mol) via hydrogen bonding, π–π stacking, and hydrophobic interactions.
- Open Access
- 30 January 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (5)
Design and Synthesis of Alpha Glycosidase Inhibitors for 1‐Benzyl‐4‐oxa‐1,9‐diazaspiro[5.5]undecan‐2‐one as an Antidiabetic Agent
A series of (4‐(trifluoromethyl)benzyl)‐linked 1,9‐diazaspiro[5.5]undecane derivatives were designed as α‐glucosidase inhibitors. We have synthesized new (4‐(trifluoromethyl)benzyl)‐linked 1,9‐diazaspiro derivatives for their antidiabetes properties. The newly synthesized compounds were examined for their inhibition activity against α‐glucosidase. The findings demonstrated that the novel synthesized compounds inhibited significantly against α‐glucosidase. Among them, SPO‐7 and SPO‐9 demonstrated the most potent inhibition, with IC 50 values of 49.96 and 63.15 nmol, respectively. Docking studies examined the orientation, interaction, and verification of the intent compounds on the active site of α‐glucosidase. The compounds SPO‐7 and SPO‐9 exhibit the highest docking energies, with values of −10.7 and −10.6 kcal/mol, respectively. In addition, the compound SPO‐7 exhibited substantial inhibition effects at all tested concentrations and their capacity to inhibit the bacterial activity against Escherichia coli and Bacillus cereus . The minimum inhibitory concentration (MIC) values for SPO‐7 and SPO‐11 were determined to be 0.156 mg/mL. Furthermore, computational drug‐likeness/ADME/toxicity tests were conducted on the compounds, which indicated that this compound exhibits drug‐like properties and possesses favorable ADME and toxicity profiles.
- 30 January 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (5)
Open AccessDesign and Synthesis of Alpha Glycosidase Inhibitors for 1‐Benzyl‐4‐oxa‐1,9‐diazaspiro[5.5]undecan‐2‐one as an Antidiabetic Agent
A series of (4‐(trifluoromethyl)benzyl)‐linked 1,9‐diazaspiro[5.5]undecane derivatives were designed as α‐glucosidase inhibitors. We have synthesized new (4‐(trifluoromethyl)benzyl)‐linked 1,9‐diazaspiro derivatives for their antidiabetes properties. The newly synthesized compounds were examined for their inhibition activity against α‐glucosidase. The findings demonstrated that the novel synthesized compounds inhibited significantly against α‐glucosidase. Among them, SPO‐7 and SPO‐9 demonstrated the most potent inhibition, with IC 50 values of 49.96 and 63.15 nmol, respectively. Docking studies examined the orientation, interaction, and verification of the intent compounds on the active site of α‐glucosidase. The compounds SPO‐7 and SPO‐9 exhibit the highest docking energies, with values of −10.7 and −10.6 kcal/mol, respectively. In addition, the compound SPO‐7 exhibited substantial inhibition effects at all tested concentrations and their capacity to inhibit the bacterial activity against Escherichia coli and Bacillus cereus . The minimum inhibitory concentration (MIC) values for SPO‐7 and SPO‐11 were determined to be 0.156 mg/mL. Furthermore, computational drug‐likeness/ADME/toxicity tests were conducted on the compounds, which indicated that this compound exhibits drug‐like properties and possesses favorable ADME and toxicity profiles.
- 19 April 2024
- Published by IGI Global Scientific Publishing
- p. 165-184
Phytochemical and Biological Properties of Anticancer Medicinal Plants From India
One of the most dreadful medical conditions in the entire world is cancer, which is the second leading cause of mortality globally. The rising threat of cancer that are resistant to treatment highlights the urgent need for the development of more potent anticancer medicines because of the drawbacks and expense of standard therapy. Alternatives to contemporary cancer treatments, like herbal medicine are fairly affordable, and few plant-based medications are used to treat it. In-vitro and in-vivo studies are conducted on the phytochemicals to determine how they work to prevent cancer. This chapter provides an overview of prospective outcomes for anticancer chemicals obtained from plants in the Indian region. Many research has confirmed the anticancer efficiency of the Phytochemicals that are extracted from plants and demonstrated that these have an essential role in battling various cancer cell lines such as breast, stomach, oral, colon, lung, hepatic, cervical, and blood cancer cell lines. Request access from your librarian to read this chapter's full text.
- 19 April 2024
- Published by IGI Global Scientific Publishing
- p. 165-184
Phytochemical and Biological Properties of Anticancer Medicinal Plants From India
One of the most dreadful medical conditions in the entire world is cancer, which is the second leading cause of mortality globally. The rising threat of cancer that are resistant to treatment highlights the urgent need for the development of more potent anticancer medicines because of the drawbacks and expense of standard therapy. Alternatives to contemporary cancer treatments, like herbal medicine are fairly affordable, and few plant-based medications are used to treat it. In-vitro and in-vivo studies are conducted on the phytochemicals to determine how they work to prevent cancer. This chapter provides an overview of prospective outcomes for anticancer chemicals obtained from plants in the Indian region. Many research has confirmed the anticancer efficiency of the Phytochemicals that are extracted from plants and demonstrated that these have an essential role in battling various cancer cell lines such as breast, stomach, oral, colon, lung, hepatic, cervical, and blood cancer cell lines. Request access from your librarian to read this chapter's full text.
- 1 May 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (5) , 870-876
Synthesis of Novel 1,3,4-Oxadiazole-functionalized Trifluoromethyl-pyrido[2,3-d]pyrimidine Derivatives and Their Anticancer Activity
Novel 1,3,4-oxadiazole-functionalized pyrido[2,3-d]pyrimidine derivatives were prepared starting from 2-amino-6-(thiophen-2-yl)-4-(trifluoromethyl)nicotinonitrile, which was reacted with trifluoroacetic acid in the presence of conc. H2SO4 and further with bromoethyl acetate to obtain ethyl 2-{4-oxo-7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-3(4H)-yl}acetate. The reaction of the latter products with hydrazine hydrate gave 2-{4-oxo-7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-3(4H)-yl}acetohydrazide. The subsequent treatment of the products with a series of aromatic acids resulted in the synthesis of 3-[(5-aryl-1,3,4-oxadiazol-2-yl)methyl]-7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-4(3H)-ones and 2-aryl-5-({[7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-4-yl]oxy}methyl)-1,3,4-oxadiazoles. All the synthesized final products were tested for anticancer activity against 4 human cancer cell lines: such as A549-Lung cancer (CCL-185), MCF7-Breast cancer (HTB-22), DU145-Prostate cancer (HTB-81), and HeLa-Cervical cancer (CCL-2). Some of the tested compounds showed promising anticancer activity.
- 1 May 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (5) , 870-876
Synthesis of Novel 1,3,4-Oxadiazole-functionalized Trifluoromethyl-pyrido[2,3-d]pyrimidine Derivatives and Their Anticancer Activity
Novel 1,3,4-oxadiazole-functionalized pyrido[2,3-d]pyrimidine derivatives were prepared starting from 2-amino-6-(thiophen-2-yl)-4-(trifluoromethyl)nicotinonitrile, which was reacted with trifluoroacetic acid in the presence of conc. H2SO4 and further with bromoethyl acetate to obtain ethyl 2-{4-oxo-7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-3(4H)-yl}acetate. The reaction of the latter products with hydrazine hydrate gave 2-{4-oxo-7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-3(4H)-yl}acetohydrazide. The subsequent treatment of the products with a series of aromatic acids resulted in the synthesis of 3-[(5-aryl-1,3,4-oxadiazol-2-yl)methyl]-7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-4(3H)-ones and 2-aryl-5-({[7-(thiophen-2-yl)-2,5-bis(trifluoromethyl)pyrido[2,3-d]pyrimidin-4-yl]oxy}methyl)-1,3,4-oxadiazoles. All the synthesized final products were tested for anticancer activity against 4 human cancer cell lines: such as A549-Lung cancer (CCL-185), MCF7-Breast cancer (HTB-22), DU145-Prostate cancer (HTB-81), and HeLa-Cervical cancer (CCL-2). Some of the tested compounds showed promising anticancer activity.
- Open Access
Molecular Hybrids of Pyazolo[3,4-b]pyridine and Triazole: Design, Synthesis and In Vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren’t enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. aureus and K. pneumoniae. The compounds 24 and 27 have been identified as the high potential molecules in this series based on in vitro experiments. Compound 24 has zone of inhibition values of 15 ± 0.82 mm and 14 ± 0.7 mm, whilst compound 27 has zone of inhibition values of 18 ± 0.95 mm and 16 ± 0.82 mm against S. aureus and K. pneumoniae, respectively. MIC and MIB values for compounds 24 and 27 against S. aureus and K. pneumoniae are 0.25 and 0.5, respectively.
Open AccessMolecular Hybrids of Pyazolo[3,4-b]pyridine and Triazole: Design, Synthesis and In Vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren’t enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. aureus and K. pneumoniae. The compounds 24 and 27 have been identified as the high potential molecules in this series based on in vitro experiments. Compound 24 has zone of inhibition values of 15 ± 0.82 mm and 14 ± 0.7 mm, whilst compound 27 has zone of inhibition values of 18 ± 0.95 mm and 16 ± 0.82 mm against S. aureus and K. pneumoniae, respectively. MIC and MIB values for compounds 24 and 27 against S. aureus and K. pneumoniae are 0.25 and 0.5, respectively.
- 21 September 2022
- Published by Springer Nature
- p. 181-197
Plant Material Assisted Magnetic Nanoparticles (MNPs) for the Separation of Inorganic Pollutants
- 21 September 2022
- Published by Springer Nature
- p. 181-197
Plant Material Assisted Magnetic Nanoparticles (MNPs) for the Separation of Inorganic Pollutants
- Open Access
- 29 August 2022
- Published by MDPI AG in Preprints.org
Molecular Hybrids of Pyrazolo[3,4-b]Pyridine and Triazole: Design, Synthesis and in vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren't enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. Aureus and K. Pneumoniae. The compounds CY-R2-25 and CY-R2-28 have been identified as the high potential molecules in this series based on in vitro experiments. CY-R2-25 has zone of inhibition values of 15 0.82 and 14 0.7, whilst CY-R2-28 has the zone of inhibition values of 18 0.95 and 16 0.82 against S. Aureus and K. Pneumoniae, respectively. MIC and MIB values for CY-R2-25 and CY-R2-28 against S. Aureus and K. Pneumoniae are 0.25 and 0.5, respectively.
- 29 August 2022
- Published by MDPI AG in Preprints.org
Open AccessMolecular Hybrids of Pyrazolo[3,4-b]Pyridine and Triazole: Design, Synthesis and in vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren't enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. Aureus and K. Pneumoniae. The compounds CY-R2-25 and CY-R2-28 have been identified as the high potential molecules in this series based on in vitro experiments. CY-R2-25 has zone of inhibition values of 15 0.82 and 14 0.7, whilst CY-R2-28 has the zone of inhibition values of 18 0.95 and 16 0.82 against S. Aureus and K. Pneumoniae, respectively. MIC and MIB values for CY-R2-25 and CY-R2-28 against S. Aureus and K. Pneumoniae are 0.25 and 0.5, respectively.
- 17 June 2022
- Published by CABI Publishing in CABI Reviews
Crop waste management: perspectives on alternative uses in India
India, which is primarily agricultural, produces approximately 683 million tonnes (MT) of crop waste. This waste is mostly used for animal feed and fuel. In India, roughly 178 MT of surplus crop leftovers and 92 MT of crop trash are burned each year because of a lack of sustainable agricultural management practices, resulting in severe air pollution. This has grown into a significant environmental issue, contributing to global warming. This crop residue burning can be prevented by adopting sustainable crop management practices through the support of government initiatives and policies. Crop waste generation, demand and feasibility differ from region to region. As a result, crop residue management plan tailored to the needs of each region should be developed. The central and state governments in India have launched a number of strategies to deal with excess crop leftovers. The majority of innovations have focused on rice husk, straw, maize waste, bagasse and banana crop waste, which account for 56% of India’s crop waste. In addition, several millet crops and cereals such as bajra, sorghum and others generate more than 352 MT of crop waste annually. These wastes are potentially available in most of the Indian states and cover 44% of crop waste, and these are not being used effectively. This review suggests advanced and practical research to develop millet crop residue management using conservation agricultural methods.
- 17 June 2022
- Published by CABI Publishing in CABI Reviews
Crop waste management: perspectives on alternative uses in India
India, which is primarily agricultural, produces approximately 683 million tonnes (MT) of crop waste. This waste is mostly used for animal feed and fuel. In India, roughly 178 MT of surplus crop leftovers and 92 MT of crop trash are burned each year because of a lack of sustainable agricultural management practices, resulting in severe air pollution. This has grown into a significant environmental issue, contributing to global warming. This crop residue burning can be prevented by adopting sustainable crop management practices through the support of government initiatives and policies. Crop waste generation, demand and feasibility differ from region to region. As a result, crop residue management plan tailored to the needs of each region should be developed. The central and state governments in India have launched a number of strategies to deal with excess crop leftovers. The majority of innovations have focused on rice husk, straw, maize waste, bagasse and banana crop waste, which account for 56% of India’s crop waste. In addition, several millet crops and cereals such as bajra, sorghum and others generate more than 352 MT of crop waste annually. These wastes are potentially available in most of the Indian states and cover 44% of crop waste, and these are not being used effectively. This review suggests advanced and practical research to develop millet crop residue management using conservation agricultural methods.
- Open Access
- 20 September 2021
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 33 (10) , 2327-2332
Synthesis and Anticancer Activity of Novel Amide Tagged Trifluoromethyl Indole and Pyrimido Indole Derivatives
A series of novel amide tagged trifluoromethyl indole and pyrimido indole derivatives 4a-e & 5a-e and 6a-d & 7a-d were synthesized from 4-methyl-2-(methylamino)-6-(trifluoromethyl)isophthalonitrile (1) on reaction with bromoethyl acetate to obtain 2a and 2b isomers. Compound 2a treated with hydrazine hydrate followed by Schiff base reaction to get compounds 4a-e. In another way, compound 2a on reaction with aliphatic primary amine to get compounds 6a-d. For cyclization, compounds 4a-e & 6a-d treated with trifluoroacetic acid to obtain compounds 5a-e and 7a-d, respectively. All the synthesized compounds 4a-e & 5a-e and 6a-d & 7a-d were tested for anticancer activity against four human cancer cell lines such as A549-lung cancer (CCL-185), MCF7-breast cancer (HTB-22), DU145-prostate cancer (HTB-81) and HeLa-cervical cancer (CCL-2). Compounds 9e and 9f were found to have promising anticancer activity at micromolar concentration.
- 20 September 2021
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 33 (10) , 2327-2332
Open AccessSynthesis and Anticancer Activity of Novel Amide Tagged Trifluoromethyl Indole and Pyrimido Indole Derivatives
A series of novel amide tagged trifluoromethyl indole and pyrimido indole derivatives 4a-e & 5a-e and 6a-d & 7a-d were synthesized from 4-methyl-2-(methylamino)-6-(trifluoromethyl)isophthalonitrile (1) on reaction with bromoethyl acetate to obtain 2a and 2b isomers. Compound 2a treated with hydrazine hydrate followed by Schiff base reaction to get compounds 4a-e. In another way, compound 2a on reaction with aliphatic primary amine to get compounds 6a-d. For cyclization, compounds 4a-e & 6a-d treated with trifluoroacetic acid to obtain compounds 5a-e and 7a-d, respectively. All the synthesized compounds 4a-e & 5a-e and 6a-d & 7a-d were tested for anticancer activity against four human cancer cell lines such as A549-lung cancer (CCL-185), MCF7-breast cancer (HTB-22), DU145-prostate cancer (HTB-81) and HeLa-cervical cancer (CCL-2). Compounds 9e and 9f were found to have promising anticancer activity at micromolar concentration.